As Philadelphia nursing home neglect lawyers, we took note of a recent study reporting that the rate of dementia is likely to rise significantly as people live longer. McKnight’s Long-Term Care News reported Feb. 25 that the University of California study predicted “epidemic” levels of dementia in people over the age of 90. For people over 100 years of age, the likelihood of having dementia is over 40%. Over the next four decades, the number of seniors over age 90 will more than quadruple.
Often, the families of patients with dementia are unable to care for them at home, so it is likely that many of these people will need care in a nursing home setting. This makes it particularly important to be vigilant for signs of abuse — for example, overmedication of patients to make them easier for the nursing home staff to manage. As we discussed recently, a nursing home company operating in Pennsylvania was accused of participating in a kickbacks scheme with pharmaceutical companies. As part of this scheme, the nursing homes had incentives to overprescribe Risperdal, an anti-psychotic drug that is used to “chemically restrain” patients with dementia. Unfortunately, patients who are unnecessarily prescribed these chemical restraints may die from them.
As Pennsylvania nursing home negligence attorneys, we help patients and their families when they find themselves victims of nursing home abuse. If you believe your loved one is a victim of over-medication by a nursing home, you should call Rosenbaum & Associates for a free consultation. You can reach us toll-free at 1-800-7-LEGAL-7 or contact us online today.